Yoram Salomon
#157,835
Most Influential Person Now
Yoram Salomon's AcademicInfluence.com Rankings
Yoram Salomonbiology Degrees
Biology
#12268
World Rank
#15732
Historical Rank
Molecular Biology
#1971
World Rank
#2003
Historical Rank
Biochemistry
#2078
World Rank
#2222
Historical Rank
Download Badge
Biology
Yoram Salomon's Degrees
- PhD Biochemistry Weizmann Institute of Science
Why Is Yoram Salomon Influential?
(Suggest an Edit or Addition)Yoram Salomon's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- A highly sensitive adenylate cyclase assay. (1974) (3714)
- Odorant-sensitive adenylate cyclase may mediate olfactory reception (1985) (541)
- Monitoring photodynamic therapy of solid tumors online by BOLD-contrast MRI (2003) (198)
- Photodynamic therapy with Pd‐bacteriopheophorbide (TOOKAD): Successful in vivo treatment of human prostatic small cell carcinoma xenografts (2003) (185)
- Evidence for interdependent action of glucagon and nucleotides on the hepatic adenylate cyclase system. (1974) (174)
- The microenvironment effect on the generation of reactive oxygen species by Pd-bacteriopheophorbide. (2005) (169)
- 5'-Guanylylimidodiphosphate, a potent activator of adenylate cyclase systems in eukaryotic cells. (1974) (164)
- Simultaneous extraction of cellular lipids and water‐soluble metabolites: Evaluation by NMR spectroscopy (1996) (145)
- Cellular responsiveness to hormones and neurotransmitters: conversion of [3H]adenine to [3H]cAMP in cell monolayers, cell suspensions, and tissue slices. (1991) (128)
- Role of adenine and guanine nucleotides in the activity and response of adenylate cyclase systems to hormones: evidence for multisite transition states. (1975) (127)
- WST11, A Novel Water-soluble Bacteriochlorophyll Derivative; Cellular Uptake, Pharmacokinetics, Biodistribution and Vascular-targeted Photodynamic Activity Using Melanoma Tumors as a Model¶ (2005) (122)
- The hepatic adenylate cyclase system. I. Evidence for transition states and structural requirements for guanine nucloetide activiation. (1975) (115)
- Preclinical Studies in Normal Canine Prostate of a Novel Palladium-Bacteriopheophorbide (WST09) Photosensitizer for Photodynamic Therapy of Prostate Cancer¶ (2002) (113)
- Photocatalytic generation of oxygen radicals by the water-soluble bacteriochlorophyll derivative WST11, noncovalently bound to serum albumin. (2009) (112)
- CONCOMITANT SYNTHESIS OF MEMBRANE PROTEIN AND EXPORTABLE PROTEIN OF THE SECRETORY GRANULE IN RAT PAROTID GLAND (1971) (109)
- Assay of adenylyl cyclase catalytic activity. (1991) (108)
- Local photodynamic therapy (PDT) of rat C6 glioma xenografts with Pd‐bacteriopheophorbide leads to decreased metastases and increase of animal cure compared with surgery (2002) (101)
- Stimulation of partially purified adenylate cyclase from bull sperm by bicarbonate (1987) (101)
- Intraovarian factors in ovulation: determinants of follicular response to gonadotrophins. (1977) (95)
- Determination of adenylyl cyclase catalytic activity using single and double column procedures. (1994) (77)
- Serine Conjugates of Chlorophyll and Bacteriochlorophyll: Photocytotoxicity in vitro and Tissue Distribution in Mice Bearing Melanoma Tumors (1996) (76)
- Systemic antitumor protection by vascular-targeted photodynamic therapy involves cellular and humoral immunity (2008) (76)
- Light‐dependent Oxygen Consumption in Bacteriochlorophyll‐Serine‐treated Melanoma Tumors: On‐line Determination Using a Tissue‐inserted Oxygen Microsensor (1997) (70)
- Permanent Occlusion of Feeding Arteries and Draining Veins in Solid Mouse Tumors by Vascular Targeted Photodynamic Therapy (VTP) with Tookad (2010) (68)
- Chlorophyll Sensitizers in Photodynamic Therapy (2006) (66)
- Novel Water-soluble Bacteriochlorophyll Derivatives for Vascular-targeted Photodynamic Therapy: Synthesis, Solubility, Phototoxicity and the Effect of Serum Proteins¶ (2005) (65)
- Identification and Possible Function of Pro‐opiomelanocortin‐derived Peptides in the Testis a (1984) (64)
- Mechanism of desensitization of adenylate cyclase by lutropin. Impaired introduction of GTP into the regulatory site. (1981) (60)
- Antivascular Treatment of Solid Melanoma Tumors with Bacteriochlorophyll–serine-based Photodynamic Therapy¶ (2001) (57)
- Antivascular Treatment of Solid Melanoma Tumors with Bacteriochlorophyll–serine‐based Photodynamic Therapy ¶ (2001) (56)
- Mechanism of desensitization of adenylate cyclase in lutropin. GTP-dependent uncoupling of the receptor. (1980) (56)
- Modulation of adenylate cyclase activity by sulfated glycosaminoglycans. I. Inhibition by heparin of gonadotrophin-stimulated ovarian adenylate cyclase. (1978) (54)
- Evidence for specific binding sites for guanine nucleotides in adipocyte and hepatocyte plasma membranes. A difference in fate of GTP and guanosine 5'-(beta, gamma-imino) triphosphate. (1975) (54)
- The hepatic adenylate cyclase system. II. Substrate binding and utilization and the effects of magnesium ion and pH. (1975) (53)
- Conversion of protein kinase to a cyclic AMP independent form by affinity chromatography on N 6 -caproyl 3',5'-cyclic adenosine monophosphate-sepharose. (1971) (51)
- G-proteins in mammalian gametes: an immunocytochemical study. (1988) (51)
- Melanocortins stimulate proliferation and induce morphological changes in cultured rat astrocytes by distinct transducing mechanisms (1992) (50)
- Photodynamic therapy of established prostatic adenocarcinoma with TOOKAD: a biphasic apparent diffusion coefficient change as potential early MRI response marker. (2004) (50)
- Protein‐A‐mediated Targeting of Bacteriochlorophyll‐IgG to Staphylococcus aureus: A Model for Enhanced Site‐Specific Photocytotoxicity (1997) (49)
- Water-filtered infrared-A radiation: a novel technique for localized hyperthermia in combination with bacteriochlorophyll-based photodynamic therapy. (1999) (48)
- Regulation of adenylate cyclase by β-melanotropin in the M2R melanoma cell line (1986) (47)
- The hepatic adenylate cyclase system. III. A mathematical model for the steady state kinetics of catalysis and nucleotide regulation. (1975) (45)
- Antitumor immunity promoted by vascular occluding therapy: lessons from vascular-targeted photodynamic therapy (VTP). (2011) (45)
- Mechanism of hormonally induced refractoriness of ovarian adenylate cyclase to luteinizing hormone and prostaglandin E. (1977) (42)
- Novel Water‐soluble Bacteriochlorophyll Derivatives for Vascular‐targeted Photodynamic Therapy: Synthesis, Solubility, Phototoxicity and the Effect of Serum Proteins ¶ (2005) (41)
- Evaluation of the new photosensitizer Stakel (WST-11) for photodynamic choroidal vessel occlusion in rabbit and rat eyes. (2008) (39)
- Perfusion, oxygenation status and growth of experimental tumors upon photodynamic therapy with Pd-bacteriopheophorbide. (2004) (38)
- Manipulation of redox signaling in mammalian cells enabled by controlled photogeneration of reactive oxygen species (2005) (37)
- Inhibition by melittin and fluphenazine of melanotropin receptor function and adenylate cyclase in M2R melanoma cell membranes. (1987) (36)
- The melanocortin receptor in the rat lacrimal gland: a model system for the study of MSH (melanocyte stimulating hormone) as a potential neurotransmitter. (1990) (36)
- Combined hyperthermia and chlorophyll-based photodynamic therapy: tumour growth and metabolic microenvironment (2003) (36)
- Bypass of tumor drug resistance by antivascular therapy. (2003) (36)
- Heparin inhibits PGE1-sensitive adenylate cyclase and antagonizes PGE1 antiaggregating effect in human platelets. (1979) (33)
- Local Oxidative Stress Expansion through Endothelial Cells – A Key Role for Gap Junction Intercellular Communication (2012) (33)
- Dual regulation of beta-melanotropin receptor function and adenylate cyclase by calcium and guanosine nucleotides in the M2R melanoma cell line. (1987) (33)
- In Vivo detection of a boron‐neutron‐capture agent in melanoma by proton observed 1H ‐ 10B double resonance (1994) (31)
- A PULSED LASER AND PULSE RADIOLYSIS STUDY OF AMPHIPHILIC CHLOROPHYLL DERIVATIVES WITH PDT ACTIVITY TOWARD MALIGNANT MELANOMA (1993) (31)
- Correlation of MR imaging and histologic findings in mouse melanoma (1992) (31)
- Europium-labeled epidermal growth factor and neurotensin: novel probes for receptor-binding studies. (2002) (31)
- Properties of LH-sensitive adenylate cyclase in purified plasma membranes from rat ovary (1978) (30)
- Modulation of adenylate cyclase activity by sulfated glycosaminoglycans. II. Effects of mucopolysaccharides and dextran sulfate on the activity of adenylate cyclase derived from various tissues. (1978) (30)
- Pseudopodia formation by secretory granules. (1972) (29)
- Stimulation of cAMP and phosphomonoester production by melanotropin in melanoma cells: 31P NMR studies. (1991) (28)
- ADP‐ribosylation of microtubule proteins as catalyzed by cholera toxin. (1982) (28)
- Bacteriochlorophyll Sensitizers in Photodynamic Therapy (2006) (28)
- Significance of prostaglandins in the regulation of cyclic events in the ovary and uterus. (1980) (27)
- The role of adenine and guanine nucleotides in the activity and response of adenylate cyclase systems to hormones: evidence for multi-site transition states. (1974) (27)
- Novel design principles enable specific targeting of imaging and therapeutic agents to necrotic domains in breast tumors (2010) (27)
- Heparin: A potent inhibitor of ovarian luteinizing hormone‐sensitive adenylate cyclase (1977) (27)
- The actions of calcitonin on the TM3 Leydig cell line and on rat Leydig cell-enriched cultures. (1989) (27)
- Melanocortin receptors: targets for control by extracellular calcium (1990) (26)
- Stiffening of rabbit corneas by the bacteriochlorophyll derivative WST11 using near infrared light. (2012) (26)
- Studies on the receptor for luteinizing hormone in a purified plasma membrane preparation from rat ovary. (1980) (24)
- The effects of dextran sulfate, heparin and PGE1 on adenylate cyclase activity and aggregation of human platelets. (1979) (23)
- In vivo imaging of the neutron capture therapy agent BSH in mice using 10B MRI (2001) (22)
- Selective labeling of proteins in biological systems by photosensitization of 5-iodonaphthalene-1-azide. (1987) (22)
- Identification and characterization of melanotropin binding proteins from M2R melanoma cells by covalent photoaffinity labeling. (1988) (21)
- Optimized 1H MRS and MRSI methods for the in vivo detection of boronophenylalanine (2005) (21)
- Prompt Assessment of WST11‐VTP Outcome Using Luciferase Transfected Tumors Enables Second Treatment and Increase in Overall Therapeutic Rate (2008) (20)
- 839 Initial results of a phase trial of WST09-mediated photodynamic therapy (WST09-PDT) for recurrent prostate cancer following failed external beam radiation therapy (EBRT) (2004) (20)
- Boron‐11 NMR of borocaptate: Relaxation and in vivo detection in melanoma‐bearing mice (1998) (20)
- A specific binding site for 3',5' cyclic AMP in rat parotid microsomes. (1970) (20)
- Do human platelets have opiate receptors? (1980) (19)
- Uptake and Washout of Borocaptate Sodium and Borono-phenylalanine in Cultured Melanoma Cells: A Multi-nuclear NMR Study (2000) (18)
- Inhibition of gonadotropin sensitive adenylate cyclase by ovarian follicular fluid. (1979) (17)
- Significant differences in the retention of the borocaptate monomer (BSH) and dimer (BSSB) in malignant cells. (2001) (16)
- Photophysical Consequences of Coupling Bacteriochlorophyll a with Serine and its Resulting Solubility in Water¶ (2000) (16)
- Synchronous generation of ovarian hCG binding sites and LH-sensitive adenylate cyclase in immature rats following treatment with pregnant mare serum gonadotropin. (1977) (16)
- Signaling Mechanisms Controlled by Melanocortins in Melanoma, Lacrimal, and Brain Astroglial Cells a (1993) (15)
- Heterogeneity of the MSH receptor among B16 murine melanoma subclones. (1991) (15)
- A synthetic analog of the calmodulin-binding domain of myosin light chain kinase inhibits melanotropin receptor function and activation of adenylate cyclase. (1988) (15)
- Homologous Adaptation to Oxidative Stress Induced by the Photosensitized Pd-bacteriochlorophyll Derivative (WST11) in Cultured Endothelial Cells* (2004) (15)
- Selective photoinduced uncoupling of the response of adenylate cyclase to gonadotropins by 5-iodonaphthyl 1-azide. (1984) (15)
- Detection of nearest neighbors to specific fluorescently tagged ligands in rod outer segment and lymphocyte plasma membranes by photosensitization of 5-iodonaphthyl 1-azide. (1989) (12)
- Detection of Light Images by Simple Tissues as Visualized by Photosensitized Magnetic Resonance Imaging (2007) (11)
- Preclinical Studies in Normal Canine Prostate of a Novel Palladium‐Bacteriopheophorbide (WST09) Photosensitizer for Photodynamic Therapy of Prostate Cancer ¶ (2002) (11)
- Inhibitors of protein tyrosine phosphorylation: preliminary assessment of activity by time-resolved fluorescence. (2000) (10)
- Noninvasive Quantitative In Vivo Mapping and Metabolism of Boronophenylalanine (BPA) by Nuclear Magnetic Resonance (NMR) Spectroscopy and Imaging (2005) (9)
- Calmodulin-binding peptides interfere with melanocyte-stimulating hormone receptor activity and stimulate adenosine 3',5'-monophosphate production in M2R mouse melanoma cells. (1994) (8)
- Regulation of adenylate cyclase by beta-melanotropin in the M2R melanoma cell line. (1986) (8)
- The role of GTP in lutropin-induced desensitization of the GTP regulatory cycle and adenylate cyclase in the rat ovary. (1981) (8)
- Synthetic peptides corresponding to the calmodulin-binding domains of skeletal muscle myosin light chain kinase and human erythrocyte Ca2+ pump interact with and permeabilize liposomes and cell membranes. (1993) (8)
- WSTO9 (TOOKAD) mediated photodynamic therapy as an alternative modality in the treatment of prostate cancer (2002) (8)
- Chlorophyll and bacteriochlorophyll, their preparation and pharmaceutical compositions comprising them (1993) (7)
- Labeling of specific proteins in rat ovarian plasma membranes with [γ‐32P]GTP (1980) (7)
- Photodynamic ablation of a selected rat embryo: a model for the treatment of extrauterine pregnancy. (2008) (7)
- Phorbol ester impairs melanotropin receptor function and stimulates growth of cultured M2R melanoma cells. (1989) (7)
- Baceriochlorophyll-serine Based Photochemotherapy; type III PDT? (1998) (7)
- Activation of a guanosine triphosphate-specific protein kinase by adenosine 3':5'-monophosphate-dependent protein kinase in rat cells of the rat. (1973) (6)
- Studies of a novel photosensitizer Pd-bacteriopheophorbide (Tookad) for the prostate cancer PDT in canine model (2003) (5)
- Inhibition by lithium of PGE1-sensitive adenylate cyclase in neuroblastoma X glioma hybrid cells: approach to the attenuation of the opiate withdrawal syndrome. (1982) (5)
- Stimulation of fructose 1,6-bisphosphate production in melanoma cells by alpha-melanocyte-stimulating hormone-- 31P/13C-NMR and 32P-labeling studies. (1998) (5)
- Calcium and Guanosine Nucleotide Modulation of Melanotropin Receptor Function and Adenylate Cyclase in the M2R Melanoma Cell Line (1987) (5)
- Application of Chlorophyll and Bacteriochlorophyll derivatives to PDT of Malignant Melanoma (1992) (5)
- Phosphorylation of proteins in rat ovarian plasma membranes by [γ-32P]GTP: evidence for the formation of a high energy phosphoprotein (1989) (4)
- WST11, A Novel Water‐soluble Bacteriochlorophyll Derivative; Cellular Uptake, Pharmacokinetics, Biodistribution and Vascular‐targeted Photodynamic Activity Using Melanoma Tumors as a Model ¶ (2005) (4)
- Vascular-targeted photodynamic therapy (VTP) of a canine-transmissible venereal tumour in a murine model with Pd-bacteriopheophorbide (WST09). (2005) (4)
- Mechanism of action of melanocortin peptides. Possible role in astrocyte regulation. (1993) (4)
- The Story of Tookad: From Bench to Bedside (2013) (4)
- The melanocyte-stimulating hormone (MSH) receptor in M2R mouse melanoma tumours: solubilization and properties of the receptor-MSH complex and its covalently crosslinked conjugate. (1993) (4)
- CHAPTER 25:Vascular-Targeted Photodynamic Therapy in Prostate Cancer: From Bench to Clinic (2016) (3)
- Signal Transduction as Studied in Living Cells by 31p-NMR: Adenylate Cyclase Activation and a Novel Phosphoethanolamine Synthesizing Pathway are Stimulated by MSH in Melanoma Cells (1992) (2)
- Inhibition by follicular fluid of luteinizing hormone-sensitive adenylate cyclase in ovarian plasma membranes. (1979) (2)
- Uncoupling of gonadotropin-sensitive adenylate cyclase by N,N′-dicyclohexylcarbodiimide Evidence for modification of two sites (1980) (2)
- 36 Photo-generated oxygen and nitroxide radicals drive tumor ablation in vascular targeted photodynamic therapy with Tookad®-Soluble: from the laboratory bench to the patient's bedside (2012) (2)
- TOOKAD® soluble VTP: From local tumor ablation to systemic cancer control (2017) (2)
- Mechanism of action of melanocortin peptides (2007) (2)
- Lutropin induced desensitization of rat ovarian adenylate cyclase: a GTP-dependent process. (1979) (2)
- 986: Photodynamic Therapy of Renal Cell Carcinoma (RCC) Xenografts in Mice, Using a Second Generation Photosensitizer·- TOOKAD (WST09) (2004) (2)
- Fluorescence detection of MSH-receptors in melanoma as a target of hormone-directed photosensitation in PDT (1995) (2)
- Studies of a novel photosensitizer palladium-bacteriopheophorbide (Tookad) for the treatment of prostate cancer (2003) (2)
- ADENYLATE CYCLASE IN THE IMMATURE RAT OVARY: INDUCTION OF RESPONSIVENESS TO LUTEINIZING HORMONE (1978) (1)
- Palladium-substituted bacteriochlorophyll derivatives and their use (1999) (1)
- Toxicological Evaluation of a New Water-Soluble Photo-Sensitizer for PDT, in the Rabbit Eye (2003) (1)
- The mechanism of gonadotropin induced desensitization of rat ovarian adenylate cyclase in the cell free state and the role of GTP in this process. (1984) (1)
- Noninvasive in-vivo Detection of Boron-10 by Magnetic Resonance (1996) (1)
- TOOKAD ) Mediated Photodynamic Therapy as an Alternative Modality in Treatment of Prostate Cancer (2002) (1)
- Determination of the response of melanoma cells to melanocyte stimulating hormone by 31P nuclear magnetic resonance spectroscopy. (1993) (1)
- The Interaction of the LH/hCG Receptor with Adenylate Cyclase in the Rat Ovary (1980) (1)
- Photo-induced inactivation and uncoupling of gonadotropin receptors in rat ovarian plasma membrane. (1980) (1)
- A novel vascular targeted photodynamic therapy (VTP) in orthotopic rat model for the treatment of esophageal cancer. (2017) (0)
- Chlorophyll and bakteriochlorophylestere, their preparation and pharmaceutical compositions comprising these esters (2000) (0)
- 38 Preventing occurrence of metastatic disease in rats with locally advanced prostate cancer by immunomodulation and vascular targeted therapy (2016) (0)
- Photophysical Consequences of Coupling Bacteriochlorophyll a with Serine and its Resulting Solubility in Water ¶ (2000) (0)
- 11 VASCULAR-TARGETED PHOTODYNAMIC THERAPY (VTP) WITH BACTERIOCHLOROPHYLL BASED SENSITISERS, A NEW STRATEGY FOR TREATMENT OF SOLID TUMORS: FROM THE LAB TO THE CLINIC (2008) (0)
- Development of Improved GNH Analogs for Controlled Reproduction of Sparus aurata in Farming Conditions (1985) (0)
- Water-soluble anionic bacteriochlorophyll derivatives and their applications (2003) (0)
- PL12 New applications of bacteriochlorophyll derivatives in photo-medicine: (1) Localization of necrotic breast tumors and (2) Photodynamic ablation of ectopic pregnancy (2010) (0)
- Abstract B012: Immunomodulated VTP enables cure of metastatic prostate and breast cancers in animal models (2016) (0)
- Labeling of specific proteins in rat ovarian plasma membranes with [gamma-32 P]GTP. (1980) (0)
- Localized photo-oxidative burst stimulates de-novo ROS/RNS generation and apoptosis in bystander cells that propagate radialy through intercellular gap junctions (2011) (0)
- Acute control of MSH-receptor function by calcium in the M2R melanoma cell line. (1987) (0)
- The treatment of esophageal cancer by vascular-targeted photodynamic therapy (VTP) using orthotopic rat model. (2015) (0)
- Chemical shift selective LASER and SI for optimized detection of Boronophenylalanine (BPA) (2005) (0)
- Cornea Stiffening of Rabbit Corneas by the Bacteriochlorophyll Derivative WST 11 Using Near Infrared Light (2012) (0)
- Synthetic derivatives substituted bacteriochlorophyll metals and use thereof. (1996) (0)
- In-vivo Penetration of WST11 to the Corneal Stroma using Dextran with Various Molecular Weights (2016) (0)
- 401P Enhancing antitumor immunity by photodynamic therapy with gemcitabine in metastatic 4T1 breast tumor. (2016) (0)
- Chlorophyll and bacteriochlorophyllester, their preparation and pharmaceutical compositions containing them (2000) (0)
- Substituted bacteriochlorophyll derivatives with palladium and use thereof. (1999) (0)
- Direct and Continuous Measurements of Oxygen Partial Pressure Using a Tissue-Inserted Optical Oxygen Microsensor: During Photodynamic Therapy (2000) (0)
- Bacterioclorofílicos derivatives water soluble anionic and their uses (2003) (0)
- 260 Tumour vascular occlusion by vascular targeted photodynamic therapy (2010) (0)
- Synthetic metal-substituted bacteriochloropyllderivate and their use (1996) (0)
- Chlorophyll and bacteriochlorophyll derivative, preparation thereof and pharmaceutical composition comprising same (1993) (0)
- Long term follow-up of stiffening of rabbit corneas by WST11 using near infrared light (2013) (0)
- MP62-07 NEOADJUVANT IMMUNOMODULATION COMBINED WITH VASCULAR TARGETED THERAPY PREVENTS METASTASES AND IMPROVES SURVIVAL IN RATS WITH LOCALLY ADVANCED PROSTATE CANCER. (2016) (0)
- bakteriochlorophyllderivate palladium Substituted and their use (1999) (0)
- Palliative treatment of obstructive esophageal cancer by vascular targeted photodynamic therapy (VTP): Preclinical study in orthotopic rat model. (2016) (0)
- Cationic bakterieklorofylderivater and uses (2005) (0)
- Derivatives of chlorophyll and bacteriochlorophyll, their preparation and pharmaceutical compositions containing them. (1993) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Yoram Salomon?
Yoram Salomon is affiliated with the following schools:
